Anyone know if any hospital starting the Expanded Access Program ( EPA ) for MK-3473 (Lambrolizumab/Pembrolizumab) is allowing melanoma patients to participate in the EPA without having taken Ipilimumab first?
The EAP is only available to those patients who have progressed on Ipi (Yervoy) or if they are BRAF positive, a BRAF and/or MEK therapy.
All things are possible through God!
Rosa is correct. Break down of EAP if you are interested: http://chaoticallypreciselifeloveandmelanoma.blogspot.com/2014/03/expanded-access-program-for-mercks-anti.html
Wishing you my best. Celeste
Meet and talk to others about melanoma in our forums:
See also: History of the MPIP Forum
–CURE OM Forum
Or, visit the MRF Chat Room!
Questions to Ask Your Doctor
Email the MRF Nurse
Get matched with a Phone Buddy
Get updates on melanoma research, education & advocacy
Helpline: (877) 673-6460
1411 K Street, NW Suite 800
Washington, DC 20005
(800) 673-1290 Office
(202) 347-9678 Fax
The Melanoma Research Foundation (MRF) is leading the melanoma community to transform melanoma from one of the deadliest cancers to one of the most treatable through research, education and advocacy.
The Melanoma Research Foundation is a 501(c)(3) non-profit organization.